Nektar TherapeuticsvsUnitedHealth

NKTR and UNH stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

Nektar Therapeutics (NKTR) has a market value of $1.1B and UnitedHealth (UNH) $300B. Over the last year, with dividends, NKTR moved -45.0% and UNH +8.2%. Dividend yield: NKTR none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    NKTR$1.1B

    UNH$300B

    UNH is 269 times NKTR

  • Revenue, 12 months

    NKTR$52M

    UNH$450B

    UNH is 8,617 times NKTR

  • Net income, 12 months

    NKTR-$177M

    UNH$15.9B

  • Operating margin

    NKTR-319.8%

    UNH5.3%

    325.0 points apart

  • ROIC

    NKTR-26.3%

    UNH11.3%

    37.6 points apart

  • P/E

    NKTR–

    UNH18.9

  • Dividend yield

    NKTR0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    NKTR-81.6%

    UNH-19.5%

    62.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

NKTR-81.6%

UNH-19.5%

05010015020222023202420252026
Returns by period
PeriodNKTRWith dividendsUNHWith dividends
1 year since November 18, 2025-45.0%Price -45.0%+8.2%Price +5.4%
3 years since November 17, 2023+351.9%+65.3% a yearPrice +351.9%-34.4%-13.1% a yearPrice -38.4%
5 years since November 18, 2021-81.6%-28.7% a yearPrice -81.6%-19.5%-4.2% a yearPrice -26.5%
10 years since November 21, 2016-83.9%-16.7% a yearPrice -83.9%+159.4%+10.0% a yearPrice +119.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

NKTRNektar TherapeuticsUNHUnitedHealth

Valuation

NKTRUNH
Valuation
Price$32.54$330.48
Market value$1.1B$300B
Enterprise value (EV)$499M$346B
P/E–18.9
P/E, 5-year median–25.0
P/B1.32.9
EV/EBIT–14.5
Free cash flow yield–7.6%

Results and growth

NKTRUNH
Results and growth
Revenue, 12 months$52M$450B
Net income, 12 months-$177M$15.9B
Free cash flow, 12 months-$257M$22.8B
Earnings per share, 12 months-$6.27$17.52
Revenue growth, year on year-43.9%11.8%
Revenue growth a year, past-18.4%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

NKTRUNH
Margins and returns on capital
Gross margin100.0%88.3%
Operating margin-319.8%5.3%
Net margin-339.7%3.5%
ROIC-26.3%11.3%
ROE-35.4%15.5%

Balance sheet

NKTRUNH
Balance sheet
Cash$614M$28.5B
Total debt$74M$74.3B
Net debt / EBITDA–1.6
Interest cover–6.2×

Dividends and buybacks

NKTRUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: NKTR or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Nektar Therapeutics or UnitedHealth?

By market value, UnitedHealth ($300B) is about 269.4 times Nektar Therapeutics ($1.1B), at today's prices.

How did NKTR and UNH stock do over the last 10 years?

Since November 21, 2016, NKTR's price moved -83.9% and UNH's +119.7%. With dividends: NKTR -83.9% (-16.7% a year), UNH +159.4% (+10.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, NKTR or UNH?

The dividend yield at today's price is none for Nektar Therapeutics and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, Nektar Therapeutics or UnitedHealth?

Over the last twelve months, the net margin was -339.7% for Nektar Therapeutics and 3.5% for UnitedHealth, and the operating margin -319.8% and 5.3%. Revenue was $52M and $450B.

Which is the better investment, Nektar Therapeutics or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.